Other meanings of Beta cell
Cell biology
Beta cells are endocrine cells in the pancreatic islets that produce, store, and secrete insulin. By adjusting insulin release to changing blood-glucose concentrations, they help regulate the movement of glucose from the bloodstream into tissues and maintain metabolic balance.1
Beta cells are specialized endocrine cells concentrated within the islets of Langerhans, microscopic clusters distributed through the exocrine pancreas. They sit alongside alpha, delta, pancreatic-polypeptide, and epsilon cells, whose hormones coordinate fuel handling and digestion.1 Beta cells manufacture insulin as a precursor called proinsulin, package it in secretory granules, and release it into nearby capillaries. Insulin then acts on liver, skeletal muscle, and adipose tissue, promoting glucose uptake or storage and restraining glucose production by the liver.2
The cell is not merely an insulin reservoir: it integrates glucose with amino acids, fatty acids, incretin hormones, and signals from the autonomic nervous system. This allows secretion to reflect both meals and the body’s longer-term energy state.
Beta cells couple glucose metabolism to electrical activity and exocytosis. Glucose enters the cell and is metabolized, raising the ATP-to-ADP ratio; ATP-sensitive potassium channels then close, the membrane depolarizes, and voltage-dependent calcium channels open. Calcium entry triggers insulin-containing granules to fuse with the plasma membrane.1
Secretion commonly has a rapid first phase followed by a slower, sustained phase. Insulin is released in pulses rather than as a perfectly continuous stream, a pattern that may improve signaling to the liver. Gut-derived incretins, especially GLP-1 and glucose-dependent insulinotropic polypeptide, amplify glucose-stimulated secretion, which is why nutrient delivery through the intestine produces a stronger response than an equivalent rise in blood glucose alone.
Diabetes can arise when beta cells produce too little insulin, release it at the wrong time, or are lost altogether. In type 1 diabetes, an autoimmune process destroys most insulin-producing cells, creating an absolute insulin deficiency that requires replacement insulin. In type 2 diabetes, insulin resistance initially makes beta cells work harder; over time, many people develop inadequate compensatory secretion alongside progressive functional impairment and, in some cases, reduced beta-cell mass.
Beta-cell stress can involve endoplasmic-reticulum stress, oxidative stress, inflammatory signaling, altered mitochondrial metabolism, and toxic exposure to persistently high glucose or fatty acids. These mechanisms interact with inherited susceptibility, obesity, age, and the local islet environment rather than forming a single disease pathway.
Beta cells are heterogeneous, and individual cells differ in maturity, insulin content, electrical behavior, and responsiveness to glucose. Some cells show unusually strong glucose responsiveness and may act as functional “hubs” that help coordinate activity across an islet, although the importance of these subpopulations remains an active research question.
Insulin is not the only product of beta cells: they also release amylin, or islet amyloid polypeptide, which normally accompanies insulin and helps regulate gastric emptying and post-meal glucagon responses. In type 2 diabetes, misfolded amylin deposits can accumulate in islets and are associated with beta-cell injury.1 Research approaches include stem-cell-derived beta cells, donor-islet transplantation, immune protection, and drugs intended to preserve or restore endogenous beta-cell function.
Beta cell is used here only for the insulin-secreting endocrine cell of the pancreatic islet.
Help improve the encyclopedia. Reports go straight to the site manager.